2018-10-18T16:03:54-07:00 2018-06-30 352317502 Bunker & Company LLP 4340 Redwood Hwy Suite 117 San Rafael CA 949032123 990 2017-07-01 942495035 GLAUCOMA RESEARCH FOUNDATION GLAU 4159863162 251 POST STREET STE 600 SAN FRANCISCO CA 94108 THOMAS M BRUNNER President & CEO 2018-10-18 true JOSEPH C BUNKER P00204452 4154997661 2017 2018-06-14 16:35:46Z THOMAS M BRUNNER 251 POST STREET STE 600 SAN FRANCISCO CA 94108 5150796 false false X www.glaucoma.org X 1978 CA THE CORPORATION WAS FORMED TO PROMOTE, SUPPORT AND OTHERWISE ENGAGE IN RESEARCH AND EDUCATION CONCERNING THE NATURE, CAUSES AND TREATMENT OF GLAUCOMA AND RELATED DISEASES OF THE EYE. 15 14 8 16 0 3230442 3729663 450743 371263 382608 525016 404449 423010 4468242 5048952 1660000 1100417 0 1131167 1124977 0 379940 1165773 1437253 3956940 3662647 511302 1386305 10590708 11586601 953992 575290 9636716 11011311 THE CORPORATION WAS FORMED TO PROMOTE, SUPPORT AND OTHERWISE ENGAGE IN RESEARCH AND EDUCATION CONCERNING THE NATURE, CAUSES AND TREATMENT OF GLAUCOMA AND RELATED DISEASES OF THE EYE. false false 3107509 THE ORGANIZATION PROMOTES AND SUPPORTS RESEARCH AND EDUCATION CONCERNING THE CAUSES AND TREATMENT OF GLAUCOMA. IT HAS BEEN A LEADER IN COLLABORATIVE RESEARCH THROUGH THE LANDMARK MULTI-CENTER NORMAL TENSION GLAUCOMA STUDY WHICH TRANSFORMED GLAUCOMA TREATMENT, AS WELL AS THE CREATION OF THE "CATALYST FOR A CURE" (CFC). THIS UNIQUE RESEARCH MODEL BRINGS TOGETHER SCIENTISTS FROM DIFFERENT DISCIPLINES TO WORK TOGETHER TO UNDERSTAND GLAUCOMA AND FIND WAYS TO IMPROVE TREATMENT AND FIND A CURE. THE FIRST CFC TEAM MADE A SIGNIFICANT IMPACT ON THE FIELD OF GLAUCOMA AND HELPED TO TRANSFORM THE UNDERSTANDING OF GLAUCOMA FROM AN EYE DISEASE TO A NEURODEGENERATIVE DISEASE.TAKING THE FINDINGS FROM THE FIRST TEAM, A SECOND CFC TEAM WAS CREATED TO DEVELOP NEW BIOMARKERS TO DIAGNOSE AND MANAGE GLAUCOMA MORE EFFECTIVELY BEFORE VISION IS LOST AND OPEN PATHWAYS TO NEW TREATMENT OPTIONS FOR PATIENTS. PLANNING FOR THE NEXT CFC COLLABORATION on vision restoration is underway. THE ORGANIZATION ALSO PROVIDES FUNDING FOR INNOVATIVE PILOT STUDIES IN GLAUCOMA RESEARCH. THESE INCUBATOR GRANTS ENABLE SCIENTISTS TO INVESTIGATE A NOVEL AND PROMISING IDEA AND GATHER CRITICAL DATA TO CONTINUE THEIR RESEARCH AND SECURE ADDITIONAL FUNDING. THIS PROGRAM CONTINUES TO NURTURE THE CAREERS OF PROMISING GLAUCOMA INVESTIGATORS AND BRING NEW IDEAS TO THE FIELD OF GLAUCOMA RESEARCH. IN ADDITION, THE ORGANIZATION SERVES AS A PRIMARY SOURCE OF INFORMATION AND SUPPORT FOR PATIENTS BY PROVIDING UNBIASED EDUCATIONAL MATERIALS IN PRINT AND ONLINE. 3107509 true true false false false false false false false true true false false true false false true false false false false false false false true false false true false true false false false false false false false false false false false true false false false false false false false false true 21 0 true 8 true false false false false false false true true false 0 false false false false false false false false false false X 15 14 false false false false false false false true true false false true true true true true true true true false CA X X X GLAUCOMA RESEARCH FOUNDATION 4159863162 251 POST ST 600 SAN FRANCISCO CA 94108 ANDREW G IWACH MD CHAIR 2.00 0.00 X X 0 0 0 THOMAS M BRUNNER President & CEO 32.00 0.00 X X 246394 0 12021 RUTH D WILLIAMS MD VICE CHAIR 2.00 0.00 X X 0 0 0 CHARLES R WILMOTH Treasurer 2.00 0.00 X X 0 0 0 RICK HALPRIN CPA Secretary 2.00 0.00 X X 0 0 0 FREDERICK H BRINKMANN Director 2.00 0.00 X 0 0 0 Martin B Wax MD Director 2.00 0.00 X 0 0 0 MONICA L VETTER PHD Director 2.00 0.00 X 0 0 0 ROBERT L STAMPER MD Director 2.00 0.00 X 0 0 0 DENNIS E SINGLETON Director 2.00 0.00 X 0 0 0 LINDA C LINCK Director 2.00 0.00 X 0 0 0 ADRIENNE L GRAVES PHD Director 2.00 0.00 X 0 0 0 TIMOTHY J DWYER Director 2.00 0.00 X 0 0 0 MONA ZANDER Director 2.00 0.00 X 0 0 0 John G Flanagan PHD Director 2.00 0.00 X 0 0 0 NANCY GRAYDON E.D. DEVEL. & COO 40.00 0.00 X 190171 0 9509 CATALINA SAN AGUSTIN DIRECTOR OPERATION 40.00 0.00 X 116172 0 5070 ANDREW JACKSON DIR. COMMUNICATION 40.00 0.00 X 112674 0 2254 665411 28854 4 false true false Elsewhere 4121 Radford Ave Studio City CA 91604 Graphic Design 168353 1 3729663 60588 3729663 CONFERENCE/FORUM 371263 371263 371263 403695 403695 0 0 0 121321 121321 121321 121321 509425 101844 407581 407581 0 0 MISCELLANEOUS 15429 15429 15429 5048952 386692 932597 1100417 1100417 0 0 0 258415 219653 19381 19381 0 866562 708693 45516 112353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 139468 115275 8095 16098 0 0 0 0 0 0 0 OTHER EXPENSES 554953 449859 33872 71222 OPERATING EXPENSES 468825 347959 13925 106941 CONSULTING EXPENSES 274007 165653 54409 53945 0 3662647 3107509 175198 379940 1263313 389215 646103 1864549 1116149 0 0 0 0 38408 25101 55498 99180 91727 77057 21556 14670 3833984 5790015 0 0 0 3513400 3506168 10590708 11586601 143992 134040 810000 441250 953992 575290 X 2460005 4711069 3834211 2957742 3342500 3342500 9636716 11011311 10590708 11586601 X 1386305 -14237 2527 X false true X true false X 3331326 2912057 3121339 3230442 3729663 16324827 0 0 3331326 2912057 3121339 3230442 3729663 16324827 4047297 12277530 174148 302156 375116 262504 1113924 0 242194 314222 221361 404449 423010 1605236 19043987 1308558 0.64470 0.62340 X 3342500 3342500 3342500 3342500 3342500 3342500 3300000 42500 3342500 1800000 1500000 3300000 1.00000 false false false 3363 3363 88364 73694 14670 14670 ASSETS HELD IN TRUST - MUTUAL FUNDS 163668 PERMANENTLY RESTRICTED INVESTMENTS 3342500 3506168 5034715 -14237 -14237 5048952 5048952 3662647 3662647 3662647 Part V, Line 4: Intended uses of the endowment fund. Permanently restricted funds are allocated as: Annual Research Grant, $800,000;Research and Annual Sutro Lecture, $2,542,000.THE ANNUAL INCOME FROM "THE DR. HENRY A. SUTRO FAMILY GRANT FOR RESEARCH" WILL BE USED FOR SPECIAL INVESTIGATIONS.THE ANNUAL INCOME FROM $1,000,000 OF THE ENDOWMENT WILL BE USED FOR THE "DRS. HENRY AND FREDERICK SUTRO MEMORIAL LECTURE" false EVENTS 509425 509425 101844 509425 509425 101844 101844 407581 true Baylor College One Baylor Plaza Houston TX 77030 741613878 40000 0 GLAUCOMA RESEARCH Case Western Reserve Univ 11100 Euclid Ave Cleveland OH 44106 341018992 40000 0 GLAUCOMA RESEARCH FIGHT FOR SIGHT 381 PARK AVE S 809 NEW YORK NY 10016 237085732 12500 0 GLAUCOMA RESEARCH GLAUCOMA REASERCH & EDUCATION 55 STEVENSON ST SAN FRANCISCO CA 94105 943208182 325000 0 GLAUCOMA RESEARCH OREGON HEALTH SCIENCE 3181 SW SAM JACKSON PK PORTLAND OR 97239 237083114 40000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY Dubra 3145 PORTER DR PALO ALTO CA 94305 941156365 100000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY Goldberg 3145 PORTER DR PALO ALTO CA 94305 941156365 100000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY Huberman 3145 PORTER DR PALO ALTO CA 94305 941156365 100000 0 GLAUCOMA RESEARCH UC DAVIS Srinivasan ONE SHIELDS AVE DAVIS CA 95616 946036494 100000 0 GLAUCOMA RESEARCH UC SAN DIEGO SHILEY EYE CTR 9500 GILMAN DR 0946 LA JOLLA CA 92093 952872494 40000 0 GLAUCOMA RESEARCH UC SAN FRANCISCO 10 KORET WAY RM K323 SAN FRANCISCO CA 94143 946036493 40000 0 GLAUCOMA RESEARCH University of Maryland 4300 Terrapin Trail College Park MD 20742 521219606 40000 0 GLAUCOMA RESEARCH UNIVERSITY OF TENNESSEE 910 MADISON AVE STE 823 MEMPHIS TN 38163 162600163 40000 0 GLAUCOMA RESEARCH University of Utah 65 M Capecchi Dr Salt Lake City UT 84132 877085732 40000 0 GLAUCOMA RESEARCH Willis Eye Hospital 840 Walnut St15th Floor Philadelphia PA 19107 236000204 40000 0 GLAUCOMA RESEARCH 15 0 X X X X X false false false false false false false false false false NANCY GRAYDON E.D. DEVEL. & COO 190171 9509 199680 THOMAS M BRUNNER President & CEO 246394 12021 258415 X 15 60588 FMV false false false Form 990, Part VI, Line 11b: Form 990 Review Process STAFF REVIEW, COPY EMAILED TO BOARD FOR REVIEW/COMMENTS Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts COMPLIANCE FORMS SENT EVERY JULY Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management Performance review by Board & Compensation Committee. Compensation Committee uses Salary Surveys and approves CEO compensation at Boards direction. Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees Annual review by supervisor and approval by next level manager with use of comparability data Form 990, Part VI, Line 19: Other Organization Documents Publicly Available UPON REQUEST Other Changes In Net Assets Or Fund Balances - Other Increases CHANGE IN VALUE CHARITABLE TRUST = $2527